ReviewPharmaceutics2022

Recent Advances in the Development of Toll-like Receptor Agonist-Based Vaccine Adjuvants for Infectious Diseases.

Jing-Xing Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.